Literature DB >> 34586462

Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma.

Charlotte Verhaeghe1, Björn Meijers2, Ann Mertens3, Peter R Sinnaeve4, Sander Jentjens5, Adinda Baten6,7, F J Sherida H Woei-A-Jin8.   

Abstract

Entities:  

Keywords:  Anaplastic large cell lymphoma; Cardiovascular diseases; Hypercholesterolemia; PCSK9 protein

Mesh：

Substances：

Year:  2021        PMID： 34586462     DOI： 10.1007/s00277-021-04679-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Abnormal lipoprotein and marked hypercholesterolemia as paraneoplastic manifestation of a renal adenocarcinoma.

Authors:  J F Lontie; D Y Dubois; Y A Carpentier
Journal:  Atherosclerosis       Date:  2001-03       Impact factor: 5.162

Review 2.  PCSK9 and inflammation: a review of experimental and clinical evidence.

Authors:  Amir Abbas Momtazi-Borojeni; Sarvenaz Sabouri-Rad; Antonio M Gotto; Matteo Pirro; Maciej Banach; Zuhier Awan; George E Barreto; Amirhossein Sahebkar
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2019-10-01

3.  3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia.

Authors:  Tetsuro Sohda; Kaoru Iwata; Genryu Hirano; Kunitoshi Sakurai; Keiji Yokoyama; Daisuke Morihara; Yasuaki Takeyama; Makoto Irie; Satoshi Shakado; Shotaro Sakisaka
Journal:  Med Mol Morphol       Date:  2013-04-03       Impact factor: 2.309

4.  Elevated paraneoplastic hypercholesterolemia in a case of hepatoid adenocarcinoma of the stomach with liver metastasis.

Authors:  Tetsuro Sohda; Hiroyuki Kusuhara; Yoshiki Egashira; Keisuke Egashira; Koichi Eguchi; Kunihiko Aoyagi; Shotaro Sakisaka
Journal:  Clin J Gastroenterol       Date:  2013-09-14

5.  Possible involvement of PCSK9 overproduction in hyperlipoproteinemia associated with hepatocellular carcinoma: A case report.

Authors:  Shuichi Nagashima; Kazue Morishima; Hiroaki Okamoto; Shun Ishibashi
Journal:  J Clin Lipidol       Date:  2016-05-14       Impact factor: 4.766
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.